Skip to main content
. 2010 Sep 20;13(9):867–872. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2010.09.06

1.

免疫组化检测肺癌中PRDM14的表达与临床病理学特征的关系

The expressions of PRDM14 and clinicopathologic characteristics in lung squamous cell carcinoma and adenocarcinoma

Characteristics n Expression of PRDM14 Z X2 P
Negative Weak Moderate Strong
Gender -0.484 0.629
  Male 40 2 5 25 9
  Female 30 6 4 11 8
Age -1.531 0.126
  <59 years 28 6 4 11 8
  ≥59 years 42 2 5 25 9
TNM stage 5.900 0.052
  Ⅰ 23 2 4 13 4
  Ⅱ 22 0 0 13 7
  Ⅲ-Ⅳ 25 6 5 2 12
Differentiation 6.147 0.046
  Highly differentiated 13 2 2 7 0
  Moderately differentiated 40 6 5 18 11
  Poorly differentiated 17 0 2 3 12
Histological type -1.982 0.047
  Squamous cell carcinoma 26 5 3 8 8
  Adencarcinoma 44 6 6 20 15
Lymphnode metastasis -1.174 0.240
  No 30 4 4 13 8
  Yes 40 4 5 15 15